KABIVEN owner Contact Information online
from Fresenius Kabi AG
KABIVEN
US serial number:85191861
Application filling date:Dec. 07, 2010
Register:Principal
Mark type:Trademark
Status:Registered. The registration date is used to determine when post-registration maintenance documents are due.
Status date:Sep. 09, 2014
Publication date:Jun. 07, 2011
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations, namely, infusion solutions for intravenous nutritional therapy and infusion solutions for intravenous parenteral nutrition
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: A
Services:Pharmaceutical preparations
namely
infusion solutions for intravenous nutritional therapy and infusion solutions for intravenous parenteral nutrition
Current owner owner name:Fresenius Kabi AG
Current owner owner address:Else-Kroener-Str. 1
Bad Homburg
GERMANY
61352
Current owner legal entity type:aktiengesellschaft
Current owner state or country:GERMANY
Attorney name:Scott D. Woldow
Attorney email:sdwoldow@sgrlaw.com
Attorney docket number:034175.028
Attorney email authorized:No
Correspondent name address:Scott D. Woldow
SMITH, GAMBRELL & RUSSELL, LLP
1055 Thomas Jefferson St., NW
Suite 400
WASHINGTON,
DISTRICT OF COLUMBIA
UNITED STATES
20007
Correspondent phone:202-973-2612
Correspondent email:sdwoldow@sgrlaw.com
docketing@sgrlaw.com
Correspondent fax:202-263-4312
Correspondent email authorized:Yes
Domestic representative name:Scott D. Woldow
Domestic representative phone:202-973-2612
Domestic representative fax:202-263-4312
Domestic representative email:sdwoldow@sgrlaw.com
Domestic representative email authorized KABIVEN:No
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (132) JOHNSON & JOHNSON (126) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Ares Trading S.A. (16)Popular publication dates
Jun. 07, 2011 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 12, 2011 Apr. 19, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010Similar brands
